A Patient’s Experience With Initial Treatment for RCC
Mr. Fuentes felt it was important to understand the range of potential side effects to anticipate how his body would potentially react to treatment for RCC and determine his physical abilities and support needs, but was most focused on whether his first post-treatment scan showed tumor shrinkage.
Recent Videos
Related Content
Hereditary Renal Tumor Syndromes and the Use of mTOR Inhibitors
José Luis Rodríguez-Olivares, MD;Héctor Raúl González-Sánchez, MD;Evelyn Lilian Beas-Lozano, MD;Jazmin Arteaga-Vázquez, MD;Elaine T. Lam, MD;María T. Bourlon, MD, MSc, FASCO
October 22nd 2024Article
A 47-year-old woman with a history of drug-resistant epilepsy during childhood presented to the emergency department with sudden dyspnea and chest pain. Upon admission, her oxygen saturation was 88%.
